Neonatal withdrawal syndrome from maternal use of drugs of addiction (Q45995): Difference between revisions
From determinar.ia.br - Determine suas informações
Created a new Item |
Changed an Item |
||||||||||||||
| (7 intermediate revisions by the same user not shown) | |||||||||||||||
| description / pt-br | description / pt-br | ||||||||||||||
A exposição intrauterina a drogas de adição pode levar a sintomas de abstinência neonatal. Os sintomas de abstinência são geralmente neurológicos, impedindo a função autonômica normal. A apresentação clínica da abstinência da droga é variável e dependente de vários fatores, como o tipo e a dose da droga utilizada e a taxa de metabolismo e excreção materna e infantil. | |||||||||||||||
| description / en | description / en | ||||||||||||||
Intrauterine exposure to addictive drugs can lead to neonatal withdrawal symptoms. Withdrawal symptoms are usually neurological, preventing normal autonomic function. The clinical presentation of drug withdrawal is variable and dependent on several factors, such as, the type and dose of drug used and rate of metabolism and excretion of the mother and infant. | |||||||||||||||
| Property / Canonical URI | |||||||||||||||
| Property / Canonical URI: https://id.who.int/icd/entity/80293156 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / CURIE | |||||||||||||||
CID11:KD35 | |||||||||||||||
| Property / CURIE: CID11:KD35 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Canary Token | |||||||||||||||
dki-india-KD35 | |||||||||||||||
| Property / Canary Token: dki-india-KD35 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Verification Status | |||||||||||||||
Concluído | |||||||||||||||
| Property / Verification Status: Concluído / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Knowledge Architect | |||||||||||||||
| Property / Knowledge Architect: https://pauloleads.com.br/cases-publicos/ / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Collection date | |||||||||||||||
13 August 2026
| |||||||||||||||
| Property / Collection date: 13 August 2026 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Linked ICD 10 | |||||||||||||||
| Property / Linked ICD 10: P96.1 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Latest revision as of 14:17, 13 August 2026
Intrauterine exposure to addictive drugs can lead to neonatal withdrawal symptoms. Withdrawal symptoms are usually neurological, preventing normal autonomic function. The clinical presentation of drug withdrawal is variable and dependent on several factors, such as, the type and dose of drug used and rate of metabolism and excretion of the mother and infant.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | KD35 |
||
| English | Neonatal withdrawal syndrome from maternal use of drugs of addiction |
Intrauterine exposure to addictive drugs can lead to neonatal withdrawal symptoms. Withdrawal symptoms are usually neurological, preventing normal autonomic function. The clinical presentation of drug withdrawal is variable and dependent on several factors, such as, the type and dose of drug used and rate of metabolism and excretion of the mother and infant. |
Statements
CID11:KD35
0 references
dki-india-KD35
0 references
Concluído
0 references
13 August 2026
0 references
